Review Article
Systemic Chemotherapy for Advanced Gastrointestinal Cancer
Abstract
The chemotherapeutic agents commonly used to treat malignant tumors of the digestive system are reviewed. Despite considerable experience with multidrug treatments, progress in the systemic treatment of advanced tumors of digestive organs has been limited. No single agent currently available has consistently given an overall response rate superior to 30%, and none of the multidrug chemotherapy regimens has consistently produced responses in more than 50% of patients treated. None of the available treatment programs has significantly prolonged the overall survival of these patients. One of the most urgent objectives of the investigative oncologist is the systematic evaluation of the efficacy of new antitumor agents in the treatment of these malignancies.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.